• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

133.28 -0.53 (-0.40%)
Streaming Delayed Price Updated: 11:37 AM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Jazz Pharmaceuticals plc - Ordinary Shares

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: 2seventy bio, Inc. (Nasdaq - TSVT), Bridge Investment Group Holdings Inc. (NYSE - BRDG), Chimerix, Inc. (Nasdaq - CMRX), 180 Degree Capital Corp. (Nasdaq – TURN)
March 11, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio
March 05, 2025
From Chimerix, Inc.; Jazz Pharmaceuticals plc
Via GlobeNewswire
Autifony Announces Exclusive Global License and Collaboration Agreement with Jazz Pharmaceuticals on Two Ion Channel Targets for Neurological Disorders
November 14, 2023
From Autifony Therapeutics Ltd
Via Business Wire
Global Cancer Vaccines Market Share Is Expected To Reach $19.27 Billion By 2030
October 25, 2023
EQNX::TICKER_START (OTCPK:DTCFF),(CSE:DTC),(NASDAQ:JAZZ),(NASDAQ:EXEL),(NASDAQ:AMGN),(NASDAQ:REGN) EQNX::TICKER_END 
Via FinancialNewsMedia
Revolutionary Cancer Treatment Advances Promise Brighter Future Amid Federal Funding Uncertainty
September 22, 2023
FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 22, 2023 – USA News Group – Despite the potential federal funding challenges due to the recent debt ceiling deal,... 
Via FinancialNewsMedia
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
September 20, 2023
Via Investor Brand Network
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
September 20, 2023
EQNX::TICKER_START (NASDAQ:GNPX),(OTCQX:RHHBY),(NASDAQ:JAZZ),(NASDAQ:ALXO),(NASDAQ:ACHL) EQNX::TICKER_END 
Via FinancialNewsMedia
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June
May 31, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:JAZZ),(NASDAQ:GERN),(NASDAQ:INAB),(NASDAQ:VCYT) EQNX::TICKER_END 
Via FinancialNewsMedia
The Global Cannabis Pharmaceuticals Market Size Is Expected To Surpass $125 Billion by 2028
April 11, 2023
EQNX::TICKER_START (OTCQX:TCNNF),(OTCQX:CURLF),(NASDAQ:TLRY),(NASDAQ:JAZZ) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Cannabis
Zymeworks Offers Hope for More than Just Long-Term Investors
March 09, 2023
Zymeworks stock is up nearly 5% since reporting earnings and a rally that has put ZYME stock over 25% in the last 12 months and could send the stock higher 
Via MarketBeat
Struggling Axsome Stock Could Bounce Back on Drug Trial Success
November 30, 2022
Axsome Pharmaceuticals may be struggling to get out of the red but the success of two very recent drug trials could quickly change all of that. 
Via MarketBeat
Three CBD Stocks to Dominate a Budding Industry
November 23, 2022
The CBD industry is growing at a high 20% CAGR and is expected to more than triple in size over the next 6 to 7 years, that's a budding opportunity. 
Via MarketBeat
Topics Cannabis
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
August 10, 2022
Via Investor Brand Network
New Drugs in Pipeline for Hypertension, the Silent Global Pandemic
August 10, 2022
NetworkNewsWire Editorial Coverage New York, NY – August 10, 2022 – In medicine, there is a term called “clinical inertia,” or the case of what someone doesn’t know — or what they ignore — could kill... 
Via FinancialNewsMedia
Global Central Nervous System Treatment Market Is Expected to Reach $166 Billion In 2028
May 26, 2022
Palm Beach, FL – May 26, 2022 – FinancialNewsMedia.com News Commentary – Worldwide, there is a rapid increase in the prevalence and incidence of neurological disorders such as multiple sclerosis,... 
Via FinancialNewsMedia
2022 Could be a Banner Year for Biotech Stocks as per top managers (SPRC, HOTH, NLSP, PSTV, IMMX, GNPX, NRBO)
January 06, 2022
Via AB Newswire
Innovators in Pharma Sectors See Potential, Promise in Providing Improved Treatments
August 05, 2021
Via FinancialNewsMedia
Agentix Corp. (AGTX) Signs Deal With NHRI To License CBD-Based Compound To Treat Type 2 Diabetes; Adds Catalyst To Back Half Of 2021
June 02, 2021
Via AB Newswire
Topics Intellectual Property
Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels
June 08, 2021
Via FinancialNewsMedia
Topics Cannabis Economy
This Could Be The Most Exciting Healthcare Development Of The Year
May 21, 2021
Via FinancialNewsMedia
Topics Artificial Intelligence Cannabis
PAO Group, Inc. Rallies 21% On Monday; Investor Update This Morning Adds Fuel To Bullish Sentiment
April 13, 2021
Via AB Newswire
Topics Cannabis Intellectual Property
Recent Quotes
View More
Symbol Price Change (%)
GOOG  250.82
+4.63 (1.88%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap